HEALTHBLOOMBERG
Tango Soars as Study Shows Its Drug Can Help Shrink Tumors
A study indicates that Tango Therapeutics' drug can help shrink tumors, leading to the company's stock surge. The findings suggest potential therapeutic benefits for cancer treatment.
Related Signal
Adjacent reporting
- Akeso To Boost Manufacturing Of Cancer Drug
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests
- GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
- Wonder pill shrinks tumours in a third of patients with six hard-to-treat cancers, early trial shows
- Weight loss jabs may help stop cancer from spreading, study reveals